| HOME >> BIOLOGY >> TECHNOLOGY |
General and administrative 5,518 4,038 10,265 7,973
Total costs and operating expenses 49,563 33,154 97,868 65,878
Loss from operations (7,513) (5,981) (10,985) (13,161)
Other income, net 191 740 1,473 1,767
Net loss before income tax benefit (7,322) (5,241) (9,512) (11,394)
Income tax benefit (expense) (204) - 136 -
Net loss $(7,526) $(5,241) $(9,376) $(11,394)
Basic and diluted net loss per share $(0.13) $(0.10) $(0.17) $(0.21)
Shares used in computing basic and
diluted net loss per share 57,054 55,149 56,603 55,081
CEPHEID
CONDENSED CONSOLIDATED UNAUDITED BALANCE SHEETS
(in thousands)
June 30, December 31,
2008 2007
ASSETS
Current assets:
Cash and cash equivalents $24,866 $16,476
Marketable securities - 27,550
Accounts receivable, net 18,573 21,263
Inventory 28,505 23,821
Prepaid expenses and other current assets 3,826 2,565
Total current assets 75,770 91,675
Property and equipment, net 22,293 17,174
Investments 21,983 -
Other non-current assets 430 923
Intangible assets 38,319 40,629
'/>"/>
| SOURCE Cepheid Copyright©2008 PR Newswire. All rights reserved |